BSE: ZYDUSLIFE - Zydus Lifesciences Limited

الربحية لمدة ستة أشهر: -8.83%
قطاع: Healthcare

جدول الترويج Zydus Lifesciences Limited


عن الشركة

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments.

مزيد من التفاصيل
It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a range of skincare products; Nycil; Glucon-D glucose powder; Nutralite; Nutralite Doodhshakti, a portfolio of dairy products; and various other products. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is based in Ahmedabad, India.

ISIN INE010B01027
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 1.34
Дивиденд ао 6
Сайт https://zyduslife.com
Цена ао 1054.35
تغير السعر يوميا: +1.37% (959.55)
تغير السعر في الأسبوع: -0.1232% (973.9)
تغير السعر شهريا: +2.31% (950.7)
تغير السعر خلال 3 أشهر: -9.48% (1074.6)
تغير السعر على مدى ستة أشهر: -8.83% (1066.95)
تغير السعر سنويا: +41.75% (686.2)
تغير السعر على مدى 3 سنوات: +119.03% (444.1)
تغير السعر على مدى 5 سنوات: +332.98% (224.65)
تغير السعر على مدى 10 سنوات: 0% (972.7)
تغير الأسعار منذ بداية العام: +0.6779% (966.15)

الاستهانة

اسم معنى درجة
P/S 5.29 2
P/BV 4.55 3
P/E 26.06 6
EV/EBITDA 14.65 7
المجموع: 5

كفاءة

اسم معنى درجة
ROA, % 14.03 4
ROE, % 20.67 7
المجموع: 4.17

توزيعات الأرباح

اسم معنى درجة
Div yield, % 0.7249 1.8
DSI 0.8571 8.57
المجموع: 2.58

واجب

اسم معنى درجة
Debt/EBITDA 0 10
المجموع: 10

دافع النمو

اسم معنى درجة
الربحية Revenue, % 37.72 5
الربحية Ebitda, % 36.84 5
الربحية EPS, % 233.73 10
المجموع: 7.2



مشرف مسمى وظيفي قسط سنة الميلاد
Dr. Sharvil Pankajbhai Patel MD & Executive Director 262.5M 1979 (46 سنين)
Dr. Ganesh Narayan Nayak COO & Executive Director 120M 1955 (70 سنين)
Mr. Punit Patel President & CEO of America N/A
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer 54.31M
Mr. Arvind Bothra Head of Investor Relations N/A
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer 2.09M

عنوان: India, Ahmedabad, Zydus Corporate Park - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://zyduslife.com